Skip to main content
Clinical Trials/NCT02916264
NCT02916264
Unknown
Phase 4

The Effect of Scalp Block on Surgical Pleth Index(SPI) During a Mayfield Head-holder Insertion in Neurosurgery : a Randomized Control Trial

Chiang Mai University1 site in 1 country30 target enrollmentJuly 2016
ConditionsPain

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Pain
Sponsor
Chiang Mai University
Enrollment
30
Locations
1
Primary Endpoint
the change of SPI from baseline
Last Updated
9 years ago

Overview

Brief Summary

It is a randomized control trial to compare the surgical plethysmographic index (SPI) response during a Mayfield head-holder insertion in neurosurgical patients who receive a scalp block versus those who do not receive the scalp block after induction of anesthesia with propofol with fentanyl and intubation with cis-atracurium.

Detailed Description

Study design is a randomized controlled trial Participants include adult neurosurgical patients scheduled to have a Mayfield head-holder insertion for supratentorial craniotomy Intervention is a scalp block prior to a Mayfield head holder insertion. Comparison is 'no scalp block' Outcome is surgical plethysmographic index (SPI) responses during/after a Mayfield head holder insertion Sample size includes 30 cases (15 cases per arm) The eligible neurosurgical patients will be randomly allocated, by a concealed randomization process, to receive or not to receive a scalp block after induction and intubation with propofol/fentanyl and cisatracurium. Surgical plethysmographic index, direct arterial blood pressure, heart rate (EEG), End tidal Carbondioxide, Bispectral/entropy (40-60) will be recorded every one minute before/after induction and intubation, before/after the scalp block, and before/after the Mayfield head-holder insertion. The Mayfield head-holder insertion will be performed by a neurosurgeon who will be blinded to the allocated groups. Data analysis is performed to compare the change of SPI during and after the Mayfield head-holder insertion from the baseline in both groups by using repeated measure ANOVA at the significant level of 0.05.

Registry
clinicaltrials.gov
Start Date
July 2016
End Date
March 2017
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sirivimol Punjasawadwong

Principal Investigator

Chiang Mai University

Eligibility Criteria

Inclusion Criteria

  • patients will receive a Mayfield head-holder insertion for supratentorial craniotomy

Exclusion Criteria

  • History of chronic hypertension, Diabetes mellitus (DM), coronary heart diseases
  • Receiving beta blockers
  • BMI \> 30
  • Coagulopathy
  • severe liver and renal diseases

Outcomes

Primary Outcomes

the change of SPI from baseline

Time Frame: 30 minutes

Study Sites (1)

Loading locations...

Similar Trials